Clinico-pathological correlation of UBE2C alterations in colorectal carcinoma and efficacy of UBE2C inhibition by proteosome inhibitor as a viable therapeutic target

被引：0

作者：

Bu, Rong ^{[1
]}

Bavi, Prashant ^{[1
]}

Hussain, Azhar R. ^{[1
]}

Jehan, Zeenath ^{[1
]}

Abubaker, Jehad ^{[1
]}

Al-Sanea, Nasser A. ^{[1
]}

Abduljabbar, Alaa S. ^{[1
]}

Ashari, Luai H. ^{[1
]}

Al-Homoud, Samar J. ^{[1
]}

Al-Dayel, Fouad ^{[1
]}

George, Thara ^{[1
]}

Qadri, Zeeshan ^{[1
]}

Hassan, Nurul ^{[1
]}

Prabhakaran, Sarita E. ^{[1
]}

Ahmed, Magbool ^{[1
]}

Uddin, Shahab ^{[1
]}

Al-Kuraya, Khawla S. ^{[1
]}

机构：

[1] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia

来源：

CANCER RESEARCH | 2011年 / 71卷

关键词：

D O I：

10.1158/1538-7445.AM2011-2980

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2980

引用

页数：1

共 50 条

[21] UBE2S and UBE2C confer a poor prognosis to breast cancer via downregulation of Numb [J].

Guo, Yanjing ;

Chen, Xinyu ;

Zhang, Xiaowei ;

Hu, Xichun .

FRONTIERS IN ONCOLOGY, 2023, 13

[22] UBE2C is involved in the functions of ECRG4 on esophageal squamous cell carcinoma [J].

Li, Linwei ;

Li, Xiaoyan ;

Wang, Wenyu ;

Gao, Tianhui ;

Shi, Zuxuan .

BIOMEDICINE & PHARMACOTHERAPY, 2018, 98 :201-206

[23] Nobiletin inhibits cell proliferation and invasion via suppression of UBE2C in hepatocellular carcinoma [J].

Su, Jinzhan ;

Fan, Shufeng ;

Su, Dongying ;

Li, Miaoer ;

Song, Xia .

SCIENCEASIA, 2024, 50 (05)

[24] Comprehensive analysis of UBE2C expression and its potential roles and mechanisms in hepatocellular carcinoma [J].

Li, Xiao ;

Ma, Zhaosheng ;

Mei, Linhang .

AGING-US, 2023, 15 (15) :7397-7407

[25] The activation of the Notch signaling pathway by UBE2C promotes the proliferation and metastasis of hepatocellular carcinoma [J].

Zhan, Ping ;

Lu, Yuyan ;

Lu, Jing ;

Cheng, Yizhe ;

Luo, Changhong ;

Yang, Fan ;

Xi, Wenqing ;

Wang, Jinzhu ;

Cen, Xuesong ;

Wang, Fuqiang ;

Xie, Chengrong ;

Yin, Zhenyu .

SCIENTIFIC REPORTS, 2024, 14 (01)

[26] UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival [J].

Nousiainen, Ruth ;

Eloranta, Katja ;

Isoaho, Noora ;

Cairo, Stefano ;

Wilson, David B. ;

Heikinheimo, Markku ;

Pihlajoki, Marjut .

FRONTIERS IN GENETICS, 2023, 14

[27] Fabrication of an immunosensor for quantitative detection of breast cancer biomarker UBE2C [J].

Jayanthi, V. S. P. K. Sankara Aditya ;

Das, Asim Bikas ;

Saxena, Urmila .

RSC ADVANCES, 2019, 9 (29) :16738-16745

[28] UBE2C is a diagnosis and therapeutic biomarker involved in immune infiltration of cancers including lung adenocarcinoma [J].

Cai, Daxia ;

Tian, Feng ;

Wu, Minhua ;

Tu, Jianfei ;

Wang, Yonghui .

JOURNAL OF CANCER, 2024, 15 (06) :1701-1717

[29] Overexpression of UBE2C correlates with poor prognosis in gastric cancer patients [J].

Zhang, H. -Q. ;

Zhao, G. ;

Ke, B. ;

Ma, G. ;

Liu, G. -L. ;

Liang, H. ;

Liu, L. -R. ;

Hao, X. -S. .

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (06) :1665-1671

[30] High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression [J].

Shen, Zhihua ;

Jiang, Xiaofan ;

Zeng, Chao ;

Zheng, Shaojiang ;

Luo, Botao ;

Zeng, Yumei ;

Ding, Ranran ;

Jiang, Hanguo ;

He, Qiyi ;

Guo, Junli ;

Jie, Wei .

BMC CANCER, 2013, 13

← 1 2 3 4 5 →